Wordt geladen...
Blockade of host β2-adrenergic receptor enhances graft-versus-tumor effect through modulating antigen presenting cells
Allogeneic hematopoietic cell transplantation (allo-HCT) is a potential curative therapy for hematologic malignancies. Host antigen presenting cells (APCs) are pivotal to the desired graft-versus-tumor (GVT) effect. Recent studies have shown that β2-adrenergic receptor (β2AR) signaling can have an i...
Bewaard in:
| Gepubliceerd in: | J Immunol |
|---|---|
| Hoofdauteurs: | , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2018
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5860988/ https://ncbi.nlm.nih.gov/pubmed/29445008 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4049/jimmunol.1701752 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|